European Case Law Identifier: | ECLI:EP:BA:2000:T096094.20000913 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 13 September 2000 | ||||||||
Case number: | T 0960/94 | ||||||||
Application number: | 84901462.6 | ||||||||
IPC class: | C07H 21/00 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Defined sequence single strand oligonucleotides incorporating reporter groups, process for the chemical synthesis thereof, and nucleosides useful in such synthesis | ||||||||
Applicant name: | SYNGENE, INC | ||||||||
Opponent name: | Roche Diagnostics GmbH Chiron Corporation |
||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | Opposition division differently composed for decisions given at oral proceedings and in writing respectively - decisions void Refusal to let party comment at oral proceedings on ground raised by another party - procedural violation |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t940960eu1.html
Date retrieved: 17 May 2021